2nd Quarter - Report
DLA PIPER LLP (US) for NOVO NORDISK INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGHAN BARRON New | — |
| NATHANIEL JAMES BELL New | Senior Legislative Assistant, Rep. Robert Andrews |
| NICOLE CARELLI | — |
| SARAH DONOVAN New | — |
| SARA FRIEDMAN New | — |
| MARY BETH LANGOWSKI | — |
| PIPER NIETERS SU | — |
| STEVEN R PHILLIPS | — |
| BETH ALLISON SCHWANKE New | — |
| JOHN SLOTMAN | — |
| TIFFANI WILLIAMS | — |
Medicare/Medicaid MMM
Issues related to Medicare and Medicaid drug rebates.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGHAN BARRON New | — |
| NATHANIEL JAMES BELL New | Senior Legislative Assistant, Rep. Robert Andrews |
| NICOLE CARELLI | — |
| SARAH DONOVAN New | — |
| SARA FRIEDMAN New | — |
| MARY BETH LANGOWSKI | — |
| PIPER NIETERS SU | — |
| JOHN SLOTMAN | — |
| TIFFANI WILLIAMS | — |
Pharmacy PHA
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARY BETH LANGOWSKI | — |
| PIPER NIETERS SU | — |
| JOHN SLOTMAN | — |
| TIFFANI WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.